Comparative sequence analysis of the VHL tumor suppressor gene

被引:48
作者
Woodward, ER
Buchberger, A
Clifford, SC
Hurst, LD
Affara, NA
Maher, ER [1 ]
机构
[1] Univ Birmingham, Sch Med, Dept Paediat & Child Hlth, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England
[2] Univ Bath, Dept Biol Sci, Bath BA2 7AY, Avon, England
[3] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[4] MRC Ctr, Ctr Prot Engn, Cambridge CB2 2QH, England
基金
英国医学研究理事会;
关键词
D O I
10.1006/geno.2000.6144
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Comparative genome analysis may provide novel insights into gene evolution and function. To investigate the von Hippel-Lindau (VHL) disease tumor suppressor gene, we sequenced the VHL gene in seven primate species. Comparative analysis was performed for human, primate, and rodent VHL genes and for a putative Caenorhabditis elegans VHL homologue identified by database analysis. The VHL gene has two translation initiation sites (at codons 1 and 54); however, the relative importance of the full-length translation product (pVHL(30)) and that translated from the second internal translation initiation site (pVHL(19)) is unclear. The N-terminal sequence of pVHL(30) contains eight copies of a GXEEX acidic repeat motif in human and higher primates, but only three copies were present in the marmoset, and only one copy was present in rodent VHL genes. Evolutionary analysis suggested that the N-terminal repetitive sequence in pVHL(30) was of less functional importance than those regions present in both pVHL(30) and pVHL(19). The VHL gene product is reported to form complexes with various proteins including elongin B, elongin C, VBP-1, fibronectin, Sp1, CUL2, and HIF-1. Although most of the regions in pVHL that had been implicated in binding specific proteins demonstrated evolutionary conservation, the carboxy-terminal putative VBP-1 binding site was less well conserved, suggesting that VBP-1 binding may have less functional significance. Although an amino acid substitution (K171T) close to the pVHL elongin binding region was found in baboon, analysis of the structure of human pVHL suggested that this substitution would not interfere with pVHL/elongin C interaction. In general, there was a good correlation between the pVHL domains that demonstrated most evolutionary conservation and those that were most frequently mutated in tumors. Analysis of human/C, elegans conservation and human germline and somatic mutation patterns identified a highly conserved mutation cluster region between codons 74 and 90. However, this region is likely to be important for the structural integrity of pVHL rather than representing an additional protein binding domain. (C) 2000 Academic Press.
引用
收藏
页码:253 / 265
页数:13
相关论文
共 44 条
[11]  
FITCH DHA, 1997, C ELEGANS, V2
[12]   SOMATIC MUTATIONS OF THE VON HIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE IN NONFAMILIAL CLEAR-CELL RENAL-CARCINOMA [J].
FOSTER, K ;
PROWSE, A ;
VANDENBERG, A ;
FLEMING, S ;
HULSBEEK, MMF ;
CROSSEY, PA ;
RICHARDS, FM ;
CAIRNS, P ;
AFFARA, NA ;
FERGUSONSMITH, MA ;
BUYS, CHCM ;
MAHER, ER .
HUMAN MOLECULAR GENETICS, 1994, 3 (12) :2169-2173
[13]  
GAO JZ, 1995, CANCER RES, V55, P743
[14]   MUTATIONS OF THE VHL TUMOR-SUPPRESSOR GENE IN RENAL-CARCINOMA [J].
GNARRA, JR ;
TORY, K ;
WENG, Y ;
SCHMIDT, L ;
WEI, MH ;
LI, H ;
LATIF, F ;
LIU, S ;
CHEN, F ;
DUH, FM ;
LUBENSKY, I ;
DUAN, DR ;
FLORENCE, C ;
POZZATTI, R ;
WALTHER, MM ;
BANDER, NH ;
GROSSMAN, HB ;
BRAUCH, H ;
POMER, S ;
BROOKS, JD ;
ISAACS, WB ;
LERMAN, MI ;
ZBAR, B ;
LINEHAN, WM .
NATURE GENETICS, 1994, 7 (01) :85-90
[15]   Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene [J].
Gnarra, JR ;
Zhou, SB ;
Merrill, MJ ;
Wagner, JR ;
Krumm, A ;
Papavassiliou, E ;
Oldfield, EH ;
Klausner, RD ;
Linehan, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10589-10594
[16]   SILENCING OF THE VHL TUMOR-SUPPRESSOR GENE BY DNA METHYLATION IN RENAL-CARCINOMA [J].
HERMAN, JG ;
LATIF, F ;
WENG, YK ;
LERMAN, MI ;
ZBAR, B ;
LIU, S ;
SAMID, D ;
DUAN, DSR ;
GNARRA, JR ;
LINEHAN, WM ;
BAYLIN, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :9700-9704
[17]   Negative regulation of hypoxia-inducible genes by the von Hippel Lindau protein [J].
Iliopoulos, O ;
Levy, AP ;
Jiang, C ;
Kaelin, WG ;
Goldberg, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10595-10599
[18]   pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation [J].
Iliopoulos, O ;
Ohh, M ;
Kaelin, WG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11661-11666
[19]   TUMOR SUPPRESSION BY THE HUMAN VON HIPPEL-LINDAU GENE-PRODUCT [J].
ILIOPOULOS, O ;
KIBEL, A ;
GRAY, S ;
KAELIN, WG .
NATURE MEDICINE, 1995, 1 (08) :822-826
[20]   The VHL tumour-suppressor gene paradigm [J].
Kaelin, WG ;
Maher, ER .
TRENDS IN GENETICS, 1998, 14 (10) :423-426